EI
PBYI icon

EAM Investors’s Puma Biotechnology PBYI Stock Holding History

EAM Investors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-272,787
Closed -$1.15M – 336
2022
Q4 		$1.15M Buy
+272,787
New +$941K 0.24% 199
2018
Q1 		– Sell
-17,987
Closed -$1.78M – 343
2017
Q4 		$1.78M Sell
17,987
-5,209
-22% -$583K 0.32% 153
2017
Q3 		$2.78M Buy
+23,196
New +$2.16M 0.37% 82
2016
Q4 		– Sell
-56,263
Closed -$3.77M – 347
2016
Q3 		$3.77M Buy
+56,263
New +$2.84M 0.51% 33
2015
Q1 		– Sell
-10,379
Closed -$1.96M – 379
2014
Q4 		$1.96M Buy
10,379
+4,920
+90% +$1.09M 0.27% 170
2014
Q3 		$1.3M Buy
+5,459
New +$1.12M 0.26% 173

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return